DEF 14A: eHealth Seeks Stockholder Approval for Amended Equity Incentive Plan

eHealth is asking stockholders to approve an amendment to its 2024 Equity Incentive Plan to increase the maximum number of shares available for issuance by 1,500,000.

Summary

• eHealth is seeking stockholder approval to amend and restate its 2024 Equity Incentive Plan to increase the maximum number of shares of common stock that may be issued thereunder by 1,500,000 shares.
• The Board believes that adopting the amended plan is in the best interests of the Company and its stockholders because it will permit the Company to continue to provide equity-based incentive awards to promote the continued success of the Company.
• The Board believes that the approval of the 2024 Amended Equity Plan is essential to the Company's continued success and ability to compete for talent in the highly competitive labor markets in which it operates.
• If stockholders approve the 2024 Amended Equity Plan, the maximum number of shares that may be issued under the 2024 Amended Equity Plan will be (a) (i) 2,850,000 shares of our common stock, plus (ii) (A) any shares that, as of immediately prior to the termination or expiration of our 2014 Equity Plan have been reserved but not issued pursuant to any awards granted under the 2014 Equity Plan and are not subject to any awards granted thereunder, plus (B) any shares subject to awards granted under the 2014 Equity Plan that, after the 2014 Equity Plan is terminated or expired, expire or otherwise terminate without having been exercised or issued in full or are forfeited to or repurchased by the Company due to failure to vest, with the maximum number of shares to be added to the 2024 Amended Equity Plan pursuant to clause (ii) above equal to 300,000 shares.

Sentiment

Score: 7

Explanation: The document is primarily informational, outlining the details of the proposed equity incentive plan amendment. The sentiment is neutral to slightly positive, as the plan is intended to benefit the company by attracting and retaining talent.

Positives

• The 2024 Amended Equity Plan includes provisions that protect the interests of stockholders and reflect sound corporate governance practices, such as no evergreen clause, no repricing of awards, and minimum vesting periods.
• The Company is committed to sound equity grant practices and is managing its annual burn rate.
• A significant portion of the Company's executive equity program is performance-based, aligning executive compensation with company performance.

Negatives

• Approval of the 2024 Amended Equity Plan will increase the potential dilution for existing shareholders.
• The Company's burn rate has been impacted by executive turnover, requiring additional equity grants for recruitment and retention.

Risks

• If the 2024 Amended Equity Plan is not approved, the Company's ability to attract and retain key personnel may be materially curtailed.
• The Company may be forced to use more of its cash resources for compensation purposes if the 2024 Amended Equity Plan is not approved.

Future Outlook

The Company anticipates that the shares available under the 2024 Amended Equity Plan will be sufficient to meet its expected needs through the grant of its 2026 annual equity awards.

Industry Context

The document notes that equity awards are considered a competitive necessity in the insurance and healthcare technology industries.

Comparison to Industry Standards

• The document compares eHealth's burn rate to that of its peer group, stating that it is in line with the peer group's burn rates.
• The document notes that eHealth's three-year average gross burn rate and net burn rate was 8.8% and 5.9% respectively, as compared to the peer 75th percentile three-year average gross burn rate and net burn rate of 7.5% and 5.0% of its peer group.

Stakeholder Impact

• Approval of the 2024 Amended Equity Plan is expected to benefit employees by providing them with equity-based incentives.
• Approval of the 2024 Amended Equity Plan is expected to benefit stockholders by aligning the interests of employees with those of stockholders and promoting the success of the Company.
• Existing stockholders may experience dilution if the 2024 Amended Equity Plan is approved.

Next Steps

• Stockholder vote on the approval of the amendment and restatement of the 2024 Equity Incentive Plan at the 2025 Annual Meeting of Stockholders.

Key Dates

Keywords

Equity Incentive Plan, Stockholder Approval, Share Reserve, Equity Awards, Compensation, eHealth